Therapeutic human anti-IL-1R1 monoclonal antibody

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9534053
APP PUB NO 20140335099A1
SERIAL NO

14198131

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antibodies that interact with interleukin-1 receptor type 1 (IL-1R1) are described. Methods of treating IL-1 mediated diseases by administering a pharmaceutically effective amount of antibodies to IL-1R1 are described. Methods of detecting the amount of IL-1R1 in a sample using antibodies to IL-1R1 are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
E R SQUIBB & SONS L L CROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08540

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Elliott, Gary Thousand Oaks, US 19 217
Huang, Haichun Fremont, US 121 4072
Martin, Francis Hall Newbury Park, US 6 88
Qian, Xueming Oaks Park, US 25 195
Varnum, Brian Santa Monica, US 5 61
Vezina, Chris Newbury Park, US 9 235
Witte, Alison Scotts Valley, US 33 353

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 3, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00